Normal mineralization and nanostructure of sclerotic bone in mice overexpressing Fra-1

Bone

Volumn 34, Issue 5, 2004, Pages 776-782

  Roschger, P ^a,f   Matsuo, K ^b,c   Misof, B M ^a   Tesch, W ^a,d   Jochum, W ^b   Wagner, E F ^b   Fratzl, P ^e   Klaushofer, K ^a  

^a Unfallkrankenhaus Meidling   (Austria)

^b RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

^c KEIO UNIVERSITY   (Japan)

^d UNIVERSITY OF LEOBEN   (Austria)

^e MAX PLANCK INSTITUTE OF COLLOIDS AND INTERFACES   (Germany)

^f LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

Fra 1; Sclerotic bone; Transgenic

Indexed keywords

PROTEIN C FOS; TRANSCRIPTION FACTOR FRA 1;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; BONE MATRIX; BONE MINERALIZATION; BONE STRUCTURE; CARTILAGE; CONTROLLED STUDY; FEMUR; IMAGING; METAPHYSIS; MORPHOMETRICS; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOPOROSIS; OSTEOSCLEROSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SCANNING SMALL ANGLE X RAY SCATTERING; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; BONE AND BONES; CALCIFICATION, PHYSIOLOGIC; MICE; MICE, TRANSGENIC; NANOTECHNOLOGY; OSTEOPOROSIS; PROTO-ONCOGENE PROTEINS C-FOS;

EID: 2342593346     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2004.01.004     Document Type: Article

References (31)

1. Bloebaum R.D., Skedros J.G., Vajda E.G., Bachus K.N., Constantz B.R. Determining mineral content variations in bone using backscattered electron imaging. Bone. 20:1997;485-490
2. Boyde A., Maconnachie E., Reid S.A., Delling G., Mundy G.R. SEM in bone pathology: review of methods, potential and applications. Scanning Electron Microsc. IV:1986;1537-1554
3. Corral D.A., Amling M., Priemel M., Loyer E., Fuchs S., Ducy P., et al. Dissociation between bone resorption and bone formation in osteopenic transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 95:1998;13835-13840
4. Dempster D.W., Cosman F., Kurland E.S., Zhou H., Nieves J., Woelfert L., et al. Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study. J. Bone Miner. Res. 16:2001;1846-1853
5. Fratzl P., Fratzl-Zelman N., Klaushofer K., Vogl G., Koller K. Nucleation and growth of mineral crystals in bone studied by small-angle X-ray scattering. Calcif. Tissue Int. 48:1991;407-413
6. Fratzl P., Groschner M., Vogl G., Plenk H. Jr., Eschberger J., Fratzl-Zelman N., et al. Mineral crystals in calcified tissues: a comparative study by SAXS. J Bone Miner. Res. 7:1992;331-336
7. Fratzl P., Roschger P., Eschberger J., Abendroth B., Klaushofer K. Abnormal bone mineralization after fluoride treatment in osteoporosis: a small angle X-ray scattering study. J. Bone Miner. Res. 9:1994;1541-1549
8. Fratzl P., Schreiber S., Klaushofer K. Bone and mineralization as studied by small-angle X-ray scattering. Connect. Tissue Res. 34:1996;247-254
9. Fratzl P., Schreiber S., Roschger P., Lafage M.H., Rodan G., Klaushofer K. Effects of sodium fluoride and alendronate on the bone mineral in minipigs: a small-angle X-ray scattering and backscattered electron imaging study. J. Bone Miner. Res. 11:1996;248-253
10. Gao H., Ji B., Jäger I.L., Arzt E., Fratzl P. Materials become insensitive to flaws at nanoscale: lessons from nature. Proc. Natl. Acad. Sci. 100:2003;5597-5600
11. Grabner B., Landis W.J., Roschger P., Rinnerthaler S., Peterlik H., Klaushofer K., et al. Age- and genotype dependence of bone material properties in the osteogenesis imperfecta murine model (oim). Bone. 29:2001;453-457
12. Grigoriadis A.E., Wang Z.Q., Cecchini M.G., Hofstetter W., Felix R., Fleisch H.A., et al. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science. 266:1994;443-448
13. Jäger I., Fratzl P. Mineralized collagen fibrils: a mechanical model with staggered arrangement of mineral particles. Biophys. J. 79:2000;1737-1746
14. Jochum W., David J.-P., Elliott C., Wutz A., Plenk H. Jr., Matsuo K., et al. Wagner, Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1. Nat. Med. 6:2000;980-984
15. Karsenty G., Wagner E.F. Reaching a genetic and molecular understanding of skeletal development. Dev. Cell. 2:2002;389-406
16. Misof B.M., Roschger P., Cosman F., Kurland E.S., Tesch W., Messmer P., et al. Effects of intermittent parathyroid hormone administration on bone mineralization density in iliac crest biopsies from patients with osteoporosis: a paired study before and after treatment. J. Clin. Endocrinol. Metab. 88:2003;1150-1156
17. Rinnerthaler S., Roschger P., Jakob H.F., Nader A., Klaushofer K., Fratzl P. Scanning small angle X-ray analysis of human bone sections. Calcif. Tissue Int. 64:1999;422-429
18. Roschger P., Plenk H. Jr., Klaushofer K., Eschberger J. A new scanning electron microscopy approach to the quantification of bone mineral density distribution: backscattered electron image grey-levels correlated to calcium K-line intensities. Scanning Microsc. 9:1995;75-88
19. Roschger P., Fratzl P., Klaushofer K., Rodan G. Mineralization of cancellous bone after alendronate and sodium fluoride treatment: a quantitative backscattered electron imaging study on minipig ribs. Bone. 20:1997;393-397
20. Roschger P., Fratzl P., Eschberger J., Klaushofer K. Validation of quantitative backscattered electron imaging for the measurement of mineral density distribution in human bone biopsies. Bone. 23:1998;319-326
21. Roschger P., Rinnerthaler S., Yates J., Rodan G.A., Fratzl P., Klaushofer K. Alendronate increases the degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic women. Bone. 29:2001;185-191
22. Roschger P., Grabner B.M., Rinnerthaler S., Tesch W., Kneissel M., Berzlanovich A., et al. Structural development of the mineralized tissue in the human L4 vertebral body. J. Struct. Biol. 136:2001;126-136
23. Roschger P., Gupta H.S., Berzlanovich A., Ittner G., Dempster D.W., Fratzl P., et al. Constant mineralization density distribution in cancellous human bone. Bone. 32:2003;316-323
24. Sabatakos G., Sims N.A., Chen J., Aoki K., Kelz M.B., Amling M., et al. Overexpression of DeltaFosB transcription factor(s) increases bone formation and inhibits adipogenesis. Nat. Med. 6:2000;985-990
25. Shaulian E., Karin M. AP-1 in cell proliferation and survival. Oncogene. 20:2001;2390-2400
26. Sogaard C.H., Mosekilde Li., Richards A., Mosekilde Le. Marked decrease in trabecular bone quality after five years of sodium fluoride therapy - assessed by biomechanical testing of iliac crest bone biopsies in osteoporotic patients. Bone. 15:1994;393-399
27. Tesch W., Eidelman N., Roschger P., Goldenberg F., Klaushofer K., Fratzl P. Graded microstructure and mechanical properties of human dentin. Calcif. Tissue Int. 69:2001;147-157
28. Wagner E.F., Karsenty G. Genetic control of skeletal development. Curr. Opin. Genet. Dev. 11:2001;527-532
29. Wang Z.Q., Ovitt C., Grigoriadis A.E., Mohle-Steinlein U., Ruther U., Wagner E.F. Bone and haematopoietic defects in mice lacking c-Fos. Nature. 360:1992;741-745
30. Zizak I., Paris O., Roschger P., Bernstorff S., Amenitsch H., Klaushofer K., et al. Investigation of bone and cartilage by synchrotron scanning-SAXS and -WAXS with micrometer spatial resolution. J. Appl. Crystallogr. 33:2000;820-823
31. Zizak I., Roschger P., Misof B.M., Berzlanovich A., Bernstorff S., Amenitsch H., et al. Characteristics of mineral particles in the human bone/cartilage interface. J. Struct. Biol. 141:2003;208-217